ArticleMedComm2025

Immunotherapy With Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors in Patients With Advanced Non-Small Cell Lung Cancers: A Multicenter, Retrospective Analysis.

Jiadi Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.